$ 0.15
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is neutral on EV/EBITDA, reasonably priced on P/FC.
Target Price
The average target price of MRMD is 0.23 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
